Topamax (topiramate) is not FDA-approved on its own for weight loss, so there is no official “normal dose” for that purpose. When prescribed off-label, doctors typically start at 25 mg per day and gradually increase to a target range of 50 to 100 mg daily, with some patients going up to 150 mg. The only FDA-approved weight loss medication containing topiramate is Qsymia, a combination pill that pairs it with phentermine at specific fixed doses.
Why There Is No Official Weight Loss Dose
The FDA approved Topamax for epilepsy and migraine prevention, not weight management. Weight loss is a well-documented side effect, which led doctors to prescribe it off-label for that purpose. Because no large-scale clinical trials have established a standardized weight loss dose the way they have for seizures or migraines, the dosing varies from provider to provider.
For its approved uses, the typical daily doses are 100 to 200 mg for epilepsy and 50 to 100 mg for migraine prevention. Off-label weight loss prescribing generally falls in a similar range, with most clinicians capping the dose at 100 mg per day. Some weight management specialists go up to 150 mg for certain patients, but higher doses bring more side effects without a proportional increase in benefit.
How Doctors Typically Start and Increase the Dose
Topiramate is almost always started low and increased slowly, a process called titration. Most prescribers begin at 25 mg once daily, usually taken in the evening. The dose is then increased by 25 mg every one to two weeks until reaching the target. This slow ramp-up is important because jumping to a full dose too quickly increases the risk of cognitive side effects and tingling in the hands and feet.
A common off-label schedule looks something like this: 25 mg daily for the first week or two, then 50 mg, then 75 mg if needed, with a typical maintenance dose landing between 50 and 100 mg per day. Some providers split the dose into morning and evening, while others prescribe the full amount as a single evening dose.
The FDA-Approved Combination: Qsymia
If you want an FDA-approved option that includes topiramate for weight loss, Qsymia is the only one. It combines phentermine (an appetite suppressant) with extended-release topiramate. The FDA approved it in 2012 for adults with a BMI of 30 or higher, or 27 or higher with a weight-related condition like high blood pressure or type 2 diabetes. It was later approved for adolescents aged 12 and older.
Qsymia comes in two main strength levels: a mid-dose version containing 7.5 mg phentermine with 46 mg topiramate, and a higher-dose version with 15 mg phentermine and 92 mg topiramate. These topiramate amounts are notably lower than what’s used for epilepsy, which reflects the fact that moderate doses can produce meaningful weight loss without the full burden of side effects.
How Much Weight Loss to Expect
Topiramate produces modest but measurable weight loss. In a study of epilepsy patients taking the drug for a year, average weight loss was about 4.1 kg (roughly 9 pounds). Patients who were obese at baseline lost more, averaging 7.3 kg (about 16 pounds), which represented an 11% reduction in body weight. Most of the weight came off in the first three months, with continued but slower loss through 12 months.
In younger patients, a study of 282 youth taking topiramate alongside lifestyle changes found BMI reductions that grew steadily over time, with the greatest improvements at the 12-month mark. The weight loss was also associated with improvements in blood sugar and cholesterol levels, suggesting metabolic benefits beyond the number on the scale.
How Topiramate Causes Weight Loss
The exact mechanism is not fully understood, but topiramate appears to work on multiple pathways at once. It increases the activity of a brain chemical called GABA, which has a calming effect and may reduce food cravings. It also blocks certain excitatory signals in the brain that drive appetite. On the metabolic side, it inhibits an enzyme involved in fat production and may increase energy expenditure. Many people taking it simply feel less hungry and more satisfied after smaller meals.
Some users also report that food, particularly sweet and carbonated foods, tastes different or less appealing. This altered taste perception likely contributes to reduced calorie intake, though it is considered a side effect rather than a primary mechanism.
Common Side Effects at Weight Loss Doses
Even at the lower doses used for weight loss, topiramate comes with a distinctive set of side effects. The most frequently reported are tingling or numbness in the fingers and toes, which affects a significant number of users but is usually mild. Cognitive effects are the bigger concern for most people. In a study of patients taking 50 to 100 mg daily, 44% reported cognitive problems after a year of treatment. The most common complaints were difficulty concentrating, slower thinking, memory lapses, and trouble finding the right word during conversation. These effects are sometimes called “brain fog” and are a leading reason people stop the medication.
Other side effects include fatigue, dizziness, and changes in taste. Topiramate also increases acid levels in the blood, which over time can raise the risk of kidney stones and weaken bones. Drinking plenty of water while taking it helps reduce the kidney stone risk.
Who Should Be Cautious
People with a history of kidney stones, kidney disease, or glaucoma should discuss these conditions with their doctor before starting topiramate. The drug can cause a specific type of eye pressure increase that, in rare cases, leads to sudden vision changes. Anyone experiencing blurred vision, eye pain, or redness while taking topiramate should seek medical attention promptly.
One concern that has been largely resolved by newer data involves birth control. The prescribing information warns that topiramate can reduce the effectiveness of hormonal contraceptives, but a large real-world study found that at doses of 200 mg per day or lower, there was no increased risk of unintended pregnancy compared to other medications. The contraception failure rate was identical in both groups: 1.3 per 100 person-years. Still, this is worth discussing with a prescriber if you rely on oral contraceptives.
How Long the Weight Loss Lasts
Weight loss from topiramate appears to be sustained for at least a year in most users who continue taking it. In one prospective study, 62% of patients maintained a lower body weight at the 12-month mark. The trajectory typically shows the steepest drop in the first three months, followed by a slower decline or plateau through the rest of the year.
What happens after stopping is less well-studied, but weight regain is common with any weight loss medication once it is discontinued. If you and your doctor decide to stop topiramate, the dose should be tapered gradually rather than stopped abruptly, as sudden discontinuation can cause seizures even in people who do not have epilepsy.